EpiCept Corporation to Present at the Rodman & Renshaw 12th Annual Global Investment Conference
9/8/2010 4:10:00 PM
[Business Wire] - TARRYTOWN, N.Y.----Regulatory News:
|
Infinity Pharmaceuticals to Present at Two Upcoming Conferences
9/8/2010 3:30:00 PM
[GlobeNewswire] - CAMBRIDGE, Mass. -- Infinity Pharmaceuticals, Inc. will be presenting at the Rodman & Renshaw Annual Global Investment Conference in New York on Wednesday, September 15, 2010 at 11:40 a.m.
|
Synta Pharmaceuticals to Present at the Robert W. Baird 2010 Health Care Conference
9/8/2010 7:00:00 AM
[Business Wire] - LEXINGTON, Mass.----Synta Pharmaceuticals Corp. , a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Robert W.
|
Abaxis, Inc. to Present at CL King's 8th Annual Best Ideas Conference 2010
9/8/2010 7:00:00 AM
[PR Newswire] - Abaxis, Inc. , a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer, will present at CL King's 8th Annual Best Ideas Conference 2010 on Wednesday, September 15, 2010 at 12:45 p.m.
|
Rosetta Genomics Reports Second Quarter 2010 Financial Results
9/7/2010 5:57:00 PM
[Business Wire] - PHILADELPHIA & REHOVOT, Israel----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three and six months ended June 30, 2010.
|
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
9/7/2010 3:05:00 PM
[Business Wire] - LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced that management will present an overview of the company at the following investor conferences during the month of September: Morgan Stanley Global Healthcare Unplugged Conference on September 13 at 1:35 p.m.
|
/ CORRECTION - SET Corp
9/7/2010 1:33:00 PM
|
Biomoda Signs Research Agreement with Saccomanno Research Institute
9/7/2010 8:25:00 AM
[Business Wire] - ALBUQUERQUE, N.M.----Cancer diagnostics company Biomoda, Inc. is working with the Saccomanno Research Institute to advance Biomoda’s patented system for measuring the photon emission rate of CyPath®-stained cells to detect early-stage lung cancer.
|
FDA OKs Quidel Pregnancy Test
9/7/2010 8:07:29 AM
|